CYTK Cytokinetics, Incorporated - Common Stock
$76.68
मूल्य · अग 19, 2026
मौलिकता इस प्रकार है अग 6, 2026
52W रेंज
$35–$88
78% of range
विश्लेषक रेटिंग
BUY
28 analysts
मूल्य लक्ष्य
$110
+43% upside
P/E (TTM)
-11.7
ROE
152.7%
शुद्ध लाभ मार्जिन
-891.6%
Cytokinetics, Incorporated - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
और पढ़ें
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
History
Cytokinetics was founded in 1997 by James Spudich, Ronald Vale, James Sabry and Lawrence S.B. Goldstein, four scientists at Stanford, UCSD, and UCSF. Operations began in 1998.
Initially, Cytokinetics focused on the possible pharmacological targets and areas of application of drugs based on cytoskeletal proteins. Eventually, the company narrowed its focus to the mechanics of muscle biology. Cytokinetics develops muscle activators and muscle inhibitors to improve muscle function in patients with cardiovascular and neuromuscular diseases.
In 2004 the company completed its initial public offering (IPO).
In January 2007, Cytokinetics named Robert I. Blum as president and CEO. Prior to this, Blum has been involved in the company since its founding, with roles in business development, corporate development and R&D.
In 2013, Cytokinetics finalized a licensing and discovery deal with Astellas to research treatment for muscle weakness and fatigue.
In July 2020, Ji Xing Pharmaceuticals signed a financing deal with Cytokinetics, which included the rights to commercialize the drug designed to treat hypertrophic cardiomyopathies, aficamten, in China and certain neighboring regions.
Products
Omecamtiv mecarbil is a cardiac muscle activator for the potential treatment of heart failure. In May 2020, omecamtiv mecarbil was granted fast track designation by the FDA for the treatment of chronic HF with reduced ejection fraction. Amgen purchased an option on omecamtiv mecarbil in 2006, and the two companies extended their partnership several times. In June 2013, Cytokinetics and Amgen expanded their licensing deal for omecamtiv mecarbil to include Japan. In November 2020 Amgen elected to terminate the collaboration, effective May 20, 2021, and Cytokinetics regained worldwide rights to develop and commercialize omecamtiv mecarbil.
Reldesemtiv (previously known as CK-2127107) is a next-generation fast skeletal muscle troponin activator (FSTA) that has undergone clinical trials for ALS.
Aficamten (previously known as CK-3773274) is an oral, small-molecule myosin inhibitor, to treat hypertrophic cardiomyopathy (HCM).
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
CYTK स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$76.67
मार्केट कैप
$9.43B
P/E (TTM)
-11.7
EPS (TTM)
$-6.54
राजस्व (TTM)
$88M
लाभांश प्रतिफल
—
ROE
152.7%
D/E ऋण/इक्विटी
-0.4
52W रेंज
$35 – $88
CYTK स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
Configure
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व और शुद्ध आय
$88M
2016-12-31
→
2025-12-31
EPS
$-6.54
2016-12-31
→
2025-12-31
फ्री कैश फ्लो
$-535M
2016-12-31
→
2025-12-31
मार्जिन
-891.6%
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
मेट्रिक
5Y रुझान
CYTK
सहकर्मी माध्यिका
P/E (TTM)
-11.7
28.5
P/S (TTM)
107.1
20.1
P/B
-14.3
12.9
EV / EBITDA
-15.9
—
Price / FCF (मूल्य / FCF)
-17.6
—
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
मेट्रिक
5Y रुझान
CYTK
सहकर्मी माध्यिका
Operating Margin (परिचालन मार्जिन)
-695.4%
—
Net Profit Margin (शुद्ध लाभ मार्जिन)
-891.6%
-48.4%
ROA
-55.5%
-28.4%
ROE
152.7%
-49.2%
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
मेट्रिक
5Y रुझान
CYTK
सहकर्मी माध्यिका
Debt / Equity (ऋण / इक्विटी)
-0.4
—
Current Ratio (वर्तमान अनुपात)
4.5
5.0
Quick Ratio (त्वरित अनुपात)
0.7
—
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
मेट्रिक
5Y रुझान
CYTK
सहकर्मी माध्यिका
Revenue YoY (राजस्व YoY)
376.6%
—
Revenue CAGR 3Y (राजस्व CAGR 3Y)
-2.4%
—
Revenue CAGR 5Y (राजस्व CAGR 5Y)
9.5%
—
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
मेट्रिक
5Y रुझान
CYTK
सहकर्मी माध्यिका
CYTK विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
खरीदें
28 विश्लेषक
- मजबूत खरीद 6 21.4%
- खरीदें 19 67.9%
- होल्ड 3 10.7%
- बेचें 0 0.0%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
20 विश्लेषक · 2026-08-18
मध्यिका
$107.50
← सभी लक्ष्यों से नीचे
$76.67
निम्न
$85.00
उच्च
$146.00
मध्यिका लक्ष्य
$107.50
+40.2%
माध्य लक्ष्य
$109.90
+43.3%
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
-0.08%
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 30 जून 2026 | $-1.50 | $-1.67 | 0.17% |
| 31 मार्च 2026 | $-1.67 | $-1.69 | 0.02% |
| 31 दिसमबर 2025 | $-1.50 | $-1.49 | -0.01% |
| 30 सितमबर 2025 | $-2.55 | $-1.61 | -0.94% |
| 30 जून 2025 | $-1.12 | $-1.41 | 0.28% |
| 31 मार्च 2025 | $-1.39 | $-1.41 | 0.02% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | — |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | — |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | — |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | — |
| PRAX | $7.43B | -21.9 | 249.5% | — | -47.3% | — |
| SMMT | $13.56B | -12.1 | — | — | -235.1% | — |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | — |
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | — |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 16
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88M | $18M | $8M | $95M | $70M | $56M | $27M | $32M | $13M | $106M | $29M | $47M | |
| R&D Expense | $416M | $339M | $330M | $241M | $160M | $97M | $86M | $89M | $90M | $60M | $46M | $44M | |
| SG&A Expense | $284M | $215M | $174M | $178M | $97M | $53M | $40M | $31M | $36M | $28M | $20M | $17M | |
| Operating Expenses | $700M | $555M | $504M | $419M | $257M | $150M | $126M | $120M | $127M | $88M | $66M | $62M | |
| Operating Income | $-612M | $-536M | $-496M | $-324M | $-186M | $-94M | $-99M | $-89M | $-113M | $19M | $-37M | $-15M | |
| Interest Expense | $46M | $38M | $28M | $19M | $16M | $16M | $7M | $4M | $3M | $3M | $268.0K | $0 | |
| Interest Income | · | · | · | $11M | $1M | $5M | $4M | $4M | · | $449.0K | $156.0K | $101.0K | |
| Other Non-op | $48M | $52M | $28M | $11M | $331.0K | $5M | $5M | $4M | $3M | $464.0K | $174.0K | $108.0K | |
| Pretax Income | · | · | · | · | · | · | · | $-106M | $-128M | $16M | $-38M | $-15M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-785M | $-590M | $-526M | $-389M | $-215M | $-127M | $-122M | $-106M | $-128M | $16M | $-38M | $-15M | |
| EPS (Basic) | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 | $-1.97 | · | · | $-2.59 | $0.41 | $-0.97 | $-0.41 | |
| EPS (Diluted) | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 | $-1.97 | · | · | $-2.59 | $0.39 | $-0.97 | $-0.41 | |
| Shares (Basic) | 120,103 | 111,979 | 96,524 | 89,825 | 76,886 | 64,524 | · | · | 49,404,000 | 39,943,000 | 38,814,000 | 35,709,000 | |
| Shares (Diluted) | 120,103 | 111,979 | 96,524 | 89,825 | 76,886 | 64,524 | · | · | 49,404,000 | 42,561,000 | 38,814,000 | 35,709,000 | |
| EBITDA | $-602M | $-527M | $-484M | $-318M | $-184M | $-92M | $-98M | $-88M | $-111M | $19M | $-37M | $-14M |
बैलेंस शीट 26
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $123M | $95M | $113M | $66M | $113M | $83M | $36M | $42M | $125M | $67M | $65M | $20M | |
| Receivables | $18M | $17M | $1M | $147.0K | $52M | $4M | $5M | $2M | $1M | $24.0K | · | · | |
| Inventory | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $17M | $15M | $12M | $12M | $12M | $6M | $3M | $2M | $4M | $2M | $2M | $1M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Assets | $917M | $1.11B | $628M | $795M | $536M | $474M | $234M | $208M | $274M | $159M | $113M | $131M | |
| PP&E (Net) | $79M | $66M | $69M | $80M | $73M | $13M | $5M | $3M | $4M | $4M | $2M | $2M | |
| PP&E (Gross) | $126M | $103M | $97M | $98M | $89M | $38M | $29M | $27M | $26M | $25M | $23M | $22M | |
| Accum. Depreciation | $47M | $37M | $28M | $17M | $16M | $25M | $24M | $24M | $23M | $21M | $21M | $20M | |
| Other Non-current Assets | $17M | $8M | $8M | $10M | $7M | $6M | · | $300.0K | $429.0K | $200.0K | $200.0K | $200.0K | |
| Total Assets | $1.42B | $1.40B | $824M | $1.01B | $841M | $534M | $290M | $211M | $295M | $170M | $115M | $133M | |
| Accounts Payable | $22M | $20M | $22M | $26M | $21M | $8M | $8M | $4M | $5M | $4M | $2M | $1M | |
| Accrued Liabilities | $83M | $55M | $43M | $44M | $34M | $19M | $12M | $16M | $17M | $18M | $8M | $5M | |
| Current Liabilities | $202M | $180M | $103M | $85M | $72M | $31M | $26M | $22M | $32M | $33M | $32M | $24M | |
| Capital Leases | $108M | $113M | $120M | $127M | $112M | $440.0K | $2M | $771.0K | · | · | · | · | |
| Other Non-current Liabilities | · | $0 | $186.0K | $1M | $4M | $0 | · | $771.0K | $1M | $142.0K | · | · | |
| Total Liabilities | $2.08B | $1.54B | $1.21B | $1.12B | $597M | $420M | $301M | $185M | $185M | $76M | $47M | $41M | |
| Long-term Debt | $288M | $620M | $639M | $650M | · | $46M | $45M | $42M | $32M | $30M | $15M | · | |
| Total Debt | $288M | $105M | $68M | $64M | $47M | $46M | $45M | $42M | $32M | $30M | $15M | · | |
| Common Stock | $123.0K | $118.0K | $102.0K | $94.0K | $84.0K | $70.0K | $59.0K | $55.0K | $54.0K | $41.0K | $40.0K | $39.0K | |
| Paid-in Capital | · | · | · | · | $1.45B | · | · | · | · | · | · | $589M | |
| Retained Earnings | $-3.49B | $-2.70B | $-2.11B | $-1.59B | $-1.21B | $-992M | $-865M | $-743M | $-646M | $-518M | $-535M | $-497M | |
| AOCI | $630.0K | $2M | $-10.0K | $-4M | $-869.0K | $149.0K | $679.0K | $500.0K | $343.0K | $137.0K | $149.0K | $-4.0K | |
| Stockholders' Equity | $-660M | $-135M | $-386M | $-108M | $244M | $113M | $-11M | $26M | $110M | $94M | $69M | $92M | |
| Liabilities + Equity | $1.42B | $1.40B | $824M | $1.01B | $841M | $534M | $290M | $211M | $295M | $170M | $115M | $133M | |
| Shares Outstanding | 122,943,172 | 118,209,139 | 101,637,922 | 94,833,975 | 84,799,542 | 71,015,183 | 59,172,124 | 54,717,906 | 53,960,832 | 40,646,595 | 39,581,692 | 38,659,738 |
नकदी प्रवाह 16
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $10M | $10M | $12M | $6M | $2M | $2M | $1M | $1M | $2M | $741.0K | $589.0K | $490.0K | |
| Stock-based Comp | $112M | $98M | $72M | $48M | $27M | $18M | $11M | $10M | $9M | $7M | $5M | $3M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | $153M | $86M | $28M | $36M | $44M | $117M | $19M | $-6M | $15M | $13M | $37M | $-34M | |
| Operating Cash Flow | $-510M | $-396M | $-414M | $-300M | $-143M | $9M | $-91M | $-101M | $-102M | $37M | $5M | $-45M | |
| CapEx | $25M | $4M | $1M | $11M | $49M | $11M | $3M | $889.0K | $3M | $2M | $562.0K | $1M | |
| Investing Cash Flow | $17M | $-553M | $239M | $-262M | $-148M | $-197M | $-75M | $5M | $-66M | · | · | · | |
| Net Debt Issued | $-11M | $-9M | · | $-48M | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | $164M | · | $0 | $0 | $36M | $0 | $112M | $0 | $9M | $49M | |
| Net Stock Activity | · | · | $164M | · | $0 | $0 | $36M | $0 | $112M | $0 | $9M | $49M | |
| Financing Cash Flow | $524M | $931M | $221M | $516M | $320M | $234M | $160M | $13M | $226M | · | · | · | |
| Net Change in Cash | $30M | $-18M | $46M | $-45M | $30M | $47M | $-6M | $-83M | $58M | $2M | $45M | $57.0K | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Free Cash Flow | $-535M | $-400M | $-416M | $-311M | $-191M | $-2M | $-94M | $-102M | $-105M | $35M | $4M | $-46M | |
| Levered FCF | · | · | · | · | · | · | · | $-106M | $-108M | $33M | · | $-46M |
लाभप्रदता 7
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -695.4% | -2902.7% | -6589.7% | -342.8% | -264.5% | -168.3% | -368.0% | -282.3% | -848.3% | 17.6% | -130.5% | -31.4% | |
| Net Margin | -891.6% | -3191.1% | -6988.6% | -411.2% | -305.7% | -228.0% | -452.9% | -337.4% | -955.9% | 15.5% | -130.9% | -31.2% | |
| Pretax Margin | · | · | · | · | · | · | · | -337.4% | -955.9% | 15.5% | -130.9% | -31.2% | |
| EBITDA Margin | -683.9% | -2851.1% | -6431.8% | -336.6% | -261.3% | -165.0% | -363.2% | -278.3% | -833.9% | 18.3% | -128.5% | -30.4% | |
| ROA | -55.5% | -53.0% | -57.2% | -41.9% | -31.3% | -30.9% | -48.6% | -42.0% | -55.0% | 11.5% | -30.2% | -13.6% | |
| ROE | 152.7% | 789.8% | 127.6% | 628.0% | -87.4% | -96.8% | 790.0% | -272.5% | -125.2% | 20.2% | -46.7% | -20.0% | |
| ROIC | · | · | · | · | · | · | · | -130.1% | -80.1% | 15.0% | -44.9% | -16.0% |
तरलता और शोधन क्षमता 5
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.2 | 6.1 | 9.4 | 7.5 | 15.2 | 9.0 | 9.4 | 8.5 | 4.8 | 3.6 | 5.5 | |
| Quick Ratio | 0.7 | 0.6 | 1.1 | 0.8 | 2.3 | 2.8 | 1.6 | 2.0 | 3.9 | 2.0 | 2.1 | 0.8 | |
| Debt / Equity | -0.4 | -0.8 | -0.2 | -0.6 | 0.2 | 0.4 | -4.1 | 1.6 | 0.3 | 0.3 | 0.2 | · | |
| LT Debt / Equity | -0.4 | -0.7 | -0.2 | -0.6 | 0.2 | 0.4 | -4.1 | 1.5 | 0.3 | 0.3 | 0.2 | · | |
| Interest Coverage | -13.4 | -14.2 | -17.5 | -16.7 | -11.3 | -5.9 | -14.9 | -23.4 | -37.6 | 6.9 | · | · |
दक्षता 2
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.7 | 0.2 | 0.4 | |
| Receivables Turnover | 5.1 | 2.1 | 10.5 | 3.6 | 2.5 | 11.7 | 7.3 | 18.8 | 23.5 | · | · | · |
विकास दरें 3
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 376.6% | 145.3% | -92.0% | 34.3% | 26.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.4% | -36.0% | -48.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM) 14
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $88M | $18M | $8M | $95M | $70M | $56M | $27M | $32M | $13M | $106M | $29M | $47M | |
| Net Income TTM | $-785M | $-590M | $-526M | $-389M | $-215M | $-127M | $-122M | $-106M | $-128M | $16M | $-38M | $-15M | |
| Market Cap | $7.81B | $5.56B | $8.49B | $4.35B | $3.87B | $1.48B | $628M | $346M | $440M | $494M | $414M | $310M | |
| Enterprise Value | $7.98B | $5.57B | $8.44B | $4.34B | $3.80B | $1.44B | $636M | $346M | $346M | $457M | $364M | · | |
| P/E | -9.7 | -8.9 | -15.3 | -10.6 | -16.3 | -10.5 | · | · | -3.1 | 31.2 | -10.8 | -19.5 | |
| P/S | 88.7 | 301.0 | 1126.9 | 45.9 | 54.9 | 26.4 | 23.4 | 11.0 | 32.9 | 4.6 | 14.4 | 6.6 | |
| P/B | -11.8 | -41.1 | -22.0 | -40.3 | 15.8 | 13.0 | -57.4 | 13.3 | 4.0 | 5.2 | 6.0 | 3.4 | |
| P / Tangible Book | · | · | · | · | 15.8 | 13.0 | · | · | · | · | · | · | |
| P / Cash Flow | -15.3 | -14.0 | -20.5 | -14.5 | -27.1 | 165.0 | -6.9 | -3.4 | -4.3 | 13.4 | 84.8 | -6.9 | |
| P / FCF | -14.6 | -13.9 | -20.4 | -14.0 | -20.2 | -699.7 | -6.7 | -3.4 | -4.2 | 14.0 | 95.8 | -6.7 | |
| EV / EBITDA | -13.2 | -10.6 | -17.4 | -13.6 | -20.6 | -15.6 | -6.5 | -3.9 | -3.1 | 23.5 | -9.9 | · | |
| EV / FCF | -14.9 | -13.9 | -20.3 | -14.0 | -19.9 | -682.3 | -6.8 | -3.4 | -3.3 | 12.9 | 84.1 | · | |
| EV / Revenue | 90.6 | 301.5 | 1121.0 | 45.9 | 54.0 | 25.8 | 23.7 | 11.0 | 25.9 | 4.3 | 12.7 | · | |
| Earnings Yield | -10.3% | -11.2% | -6.5% | -9.4% | -6.1% | -9.5% | · | · | -31.8% | 3.2% | -9.3% | -5.1% |
आय विवरण 14
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $19M | $18M | $2M | $67M | $2M | $17M | $463.0K | $249.0K | $835.0K | $2M | $378.0K | $867.0K | $5M | $2M | $3M | |
| R&D Expense | $98M | $96M | $104M | $99M | $110M | $98M | $94M | $85M | $80M | $82M | $85M | $83M | $83M | $79M | $75M | $63M | |
| SG&A Expense | $104M | $105M | $92M | $69M | $66M | $57M | $62M | $57M | $51M | $46M | $44M | $40M | $40M | $50M | $54M | $48M | |
| Operating Expenses | $208M | $203M | $196M | $169M | $178M | $157M | $156M | $141M | $130M | $127M | $129M | $123M | $123M | $129M | $129M | $111M | |
| Operating Income | $-179M | $-184M | $-178M | $-167M | $-112M | $-156M | $-139M | $-141M | $-130M | $-126M | $-127M | $-122M | $-122M | $-124M | $-127M | $-108M | |
| Interest Expense | · | · | $14M | $11M | $11M | · | $9M | $9M | $13M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Other Non-op | $14M | $11M | $11M | $10M | $13M | $14M | $15M | $17M | $12M | $8M | $8M | $7M | $7M | $6M | $6M | $4M | |
| Net Income | $-199M | $-206M | $-183M | $-306M | $-134M | $-161M | $-150M | $-161M | $-143M | $-136M | $-137M | $-129M | $-129M | $-131M | $-137M | $-142M | |
| EPS (Basic) | $-1.50 | $-1.67 | $-1.51 | $-2.55 | $-1.12 | $-1.36 | $-1.26 | $-1.36 | $-1.31 | $-1.33 | $-1.38 | $-1.35 | $-1.34 | $-1.38 | $-1.53 | $-1.52 | |
| EPS (Diluted) | $-1.50 | $-1.67 | $-1.51 | $-2.55 | $-1.12 | $-1.36 | $-1.26 | $-1.36 | $-1.31 | $-1.33 | $-1.38 | $-1.35 | $-1.34 | $-1.38 | $-1.53 | $-1.52 | |
| Shares (Basic) | 132,086 | 123,273 | -237,832 | 119,982 | 119,457 | 118,496 | -216,870 | 117,685 | 109,240 | 101,924 | -190,466 | 96,071 | 95,755 | 95,164 | -174,660 | 93,758 | |
| Shares (Diluted) | 132,086 | 123,273 | -237,832 | 119,982 | 119,457 | 118,496 | -216,870 | 117,685 | 109,240 | 101,924 | -190,466 | 96,071 | 95,755 | 95,164 | -174,660 | 93,758 | |
| EBITDA | $-179M | $-180M | · | $-167M | $-112M | $-153M | · | $-141M | $-130M | $-124M | · | $-122M | $-122M | $-123M | · | $-108M |
बैलेंस शीट 24
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $255M | $130M | $123M | $225M | $75M | $74M | $95M | $47M | $190M | $120M | · | $100M | $69M | $102M | · | $106M | |
| Receivables | $24M | $7M | $18M | $2M | $8M | $2M | $17M | $244.0K | $0 | $834.0K | · | $2M | $985.0K | $1M | · | $2M | |
| Inventory | $380.0K | $154.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $18M | $14M | $17M | $13M | $20M | $16M | $15M | $7M | $11M | $19M | · | $20M | $20M | $16M | · | $14M | |
| Current Assets | $1.21B | $839M | $917M | $977M | $887M | $956M | $1.11B | $1.02B | $1.07B | $639M | · | $561M | $587M | $681M | · | $884M | |
| PP&E (Net) | $79M | $82M | $79M | $76M | $70M | $67M | $66M | $64M | $66M | $68M | · | $76M | $77M | $79M | · | $80M | |
| PP&E (Gross) | · | · | $126M | · | · | · | $103M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $47M | · | · | · | $37M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $19M | $18M | $17M | $17M | $15M | $13M | $8M | $8M | $8M | $8M | · | $8M | $8M | $8M | · | · | |
| Total Assets | $1.92B | $1.27B | $1.42B | $1.44B | $1.23B | $1.26B | $1.40B | $1.44B | $1.52B | $808M | · | $741M | $780M | $890M | · | $1.08B | |
| Accounts Payable | $21M | $25M | $22M | $22M | $16M | $14M | $20M | $12M | $9M | $13M | · | $14M | $13M | $17M | · | $14M | |
| Accrued Liabilities | $77M | $69M | $83M | $62M | $52M | $43M | $55M | $50M | $40M | $40M | · | $33M | $31M | $36M | · | $40M | |
| Current Liabilities | $181M | $199M | $202M | $142M | $131M | $160M | $180M | $110M | $103M | $89M | · | $78M | $66M | $75M | · | $76M | |
| Capital Leases | $102M | $105M | $108M | $111M | $111M | $113M | $113M | $115M | $117M | $119M | · | $122M | $124M | $125M | · | $114M | |
| Other Non-current Liabilities | · | · | · | $2M | $2M | $3M | · | $0 | $0 | $2.0K | · | $408.0K | $625.0K | $837.0K | · | $1M | |
| Total Liabilities | $2.10B | $2.10B | $2.08B | $1.96B | $1.59B | $1.53B | $1.54B | $1.45B | $1.42B | $1.20B | · | $1.18B | $1.11B | $1.12B | · | $1.09B | |
| Long-term Debt | $276M | $292M | $288M | $1.00B | $610M | $610M | $105M | $620M | $629M | $630M | · | · | · | · | · | · | |
| Total Debt | $276M | $292M | · | $176M | $173M | $105M | · | $105M | $104M | $68M | · | $61M | $62M | $64M | · | $64M | |
| Common Stock | $138.0K | $124.0K | $123.0K | $122.0K | $119.0K | $119.0K | $118.0K | $118.0K | $117.0K | $105.0K | · | $94.0K | $94.0K | $94.0K | · | $93.0K | |
| Retained Earnings | $-3.89B | $-3.69B | $-3.49B | $-3.30B | $-3.00B | $-2.86B | $-2.70B | $-2.55B | $-2.39B | $-2.25B | · | $-1.98B | $-1.85B | $-1.72B | · | $-1.45B | |
| AOCI | $-4M | $-2M | $630.0K | $34.0K | $-158.0K | $2M | $2M | $5M | $-1M | $-539.0K | · | $-874.0K | $-1M | $-2M | · | $-6M | |
| Stockholders' Equity | $-173M | $-827M | $-660M | $-521M | $-369M | $-266M | $-135M | $-14M | $109M | $-396M | $-386M | $-439M | $-333M | $-229M | $-108M | $-16M | |
| Liabilities + Equity | $1.92B | $1.27B | $1.42B | $1.44B | $1.23B | $1.26B | $1.40B | $1.44B | $1.52B | $808M | · | $741M | $780M | $890M | · | $1.08B | |
| Shares Outstanding | · | · | 122,943,172 | · | · | · | 118,209,139 | · | · | · | · | · | · | · | · | · |
नकदी प्रवाह 12
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $6M | $2M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $36M | $30M | $31M | $31M | $28M | $24M | $26M | $25M | $25M | $22M | $19M | $19M | $19M | $15M | $13M | $13M | |
| Other Non-cash | · | $27M | · | · | · | $4M | · | · | · | $-18M | · | · | · | $-8M | · | · | |
| Operating Cash Flow | $-160M | $-145M | $-143M | $-108M | $-128M | $-132M | $-66M | $-102M | $-99M | $-130M | $-74M | $-96M | $-122M | $-122M | $-98M | $-84M | |
| CapEx | $4M | $6M | $6M | $9M | $4M | $6M | $1M | $701.0K | $2M | $0 | $77.0K | $220.0K | $717.0K | $402.0K | $3M | $6M | |
| Investing Cash Flow | $-507M | $145M | $-71M | $-71M | $53M | $106M | $111M | $-45M | $-652M | $33M | $-81M | $73M | $82M | $165M | $29M | $-292M | |
| Net Debt Issued | · | $-3M | · | · | · | $-3M | · | · | · | $-705.0K | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | $0 | $0 | · | · | · | $94M | · | · | · | $0 | · | · | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $94M | · | · | · | · | · | · | |
| Financing Cash Flow | $793M | $8M | $111M | $330M | $79M | $5M | $2M | $3M | $821M | $104M | $169M | $54M | $5M | $-7M | $30M | $389M | |
| Net Change in Cash | $125M | $7M | $-103M | $152M | $2M | $-21M | $48M | $-143M | $70M | $7M | $13M | $31M | $-34M | $36M | $-39M | $13M | |
| Free Cash Flow | · | $-151M | · | · | · | $-137M | · | · | · | $-130M | · | · | · | $-123M | · | · |
लाभप्रदता 5
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -626.0% | -948.7% | · | -8613.4% | -167.0% | -9856.3% | · | -30410.6% | -52277.9% | -15118.0% | · | -32345.2% | -14077.2% | -2698.3% | · | -4311.8% | |
| Net Margin | -694.4% | -1064.5% | · | -15815.0% | -201.3% | -10220.1% | · | -34675.0% | -57557.4% | -16244.7% | · | -34238.6% | -14837.0% | -2846.1% | · | -5658.4% | |
| EBITDA Margin | -626.0% | -931.2% | · | -8613.4% | -167.0% | -9710.6% | · | -30410.6% | -52277.9% | -14838.8% | · | -32345.2% | -14077.2% | -2658.2% | · | -4311.8% | |
| ROA | -12.6% | -16.2% | · | -21.3% | -9.8% | -15.6% | · | -14.8% | -12.4% | -16.0% | · | -14.2% | -16.6% | -15.0% | · | -14.9% | |
| ROE | 73.3% | 37.7% | · | 114.5% | 103.3% | 48.7% | · | 70.9% | 127.6% | 43.4% | · | 56.9% | 116.1% | 232.9% | · | -122.1% |
तरलता और शोधन क्षमता 5
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.7 | 4.2 | · | 6.9 | 6.8 | 6.0 | · | 9.3 | 10.4 | 7.2 | · | 7.2 | 8.9 | 9.0 | · | 11.6 | |
| Quick Ratio | 1.5 | 0.7 | · | 1.6 | 0.6 | 0.5 | · | 0.4 | 1.9 | 1.4 | · | 1.3 | 1.1 | 1.4 | · | 1.4 | |
| Debt / Equity | -1.6 | -0.4 | · | -0.3 | -0.5 | -0.4 | · | -7.5 | 1.0 | -0.2 | · | -0.1 | -0.2 | -0.3 | · | -4.0 | |
| LT Debt / Equity | -1.4 | -0.3 | · | -0.3 | -0.4 | -0.3 | · | -6.7 | 0.9 | -0.1 | · | -0.1 | -0.2 | -0.3 | · | -4.0 | |
| Interest Coverage | · | · | · | -14.7 | -10.1 | · | · | -15.8 | -10.2 | -17.8 | · | -17.1 | -17.3 | -17.9 | · | -15.9 |
दक्षता 2
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 1.7 | 4.4 | · | 1.9 | 15.9 | 1.1 | · | 0.3 | 0.5 | 0.9 | · | 0.2 | 0.6 | 1.3 | · | 1.7 |
मूल्यांकन (TTM) 4
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117M | $90M | · | $71M | $69M | $3M | · | $2M | $2M | $7M | · | $8M | $97M | $97M | · | $98M | |
| Net Income TTM | $-845M | $-808M | · | $-762M | $-600M | $-601M | · | $-569M | $-537M | $-525M | · | $-532M | $-422M | $-383M | · | $-328M | |
| P/E | -12.5 | -9.8 | · | -8.6 | -6.4 | -7.5 | · | -9.9 | -10.2 | -13.0 | · | -5.3 | -7.3 | -8.4 | · | -12.9 | |
| Earnings Yield | -8.0% | -10.2% | · | -11.6% | -15.6% | -13.3% | · | -10.1% | -9.8% | -7.7% | · | -19.0% | -13.7% | -11.9% | · | -7.7% |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| राजस्व | $88M | $18M | $8M | $95M | $70M |
| परिचालन मार्जिन % | -695.4% | -2902.7% | -6589.7% | -342.8% | -264.5% |
| शुद्ध आय | $-785M | $-590M | $-526M | $-389M | $-215M |
| तनुकरणित EPS | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 |
बैलेंस शीट
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| ऋण / इक्विटी | -0.4 | -0.8 | -0.2 | -0.6 | 0.2 |
| वर्तमान अनुपात | 4.5 | 6.2 | 6.1 | 9.4 | 7.5 |
| त्वरित अनुपात | 0.7 | 0.6 | 1.1 | 0.8 | 2.3 |
नकदी प्रवाह
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $-535M | $-400M | $-416M | $-311M | $-191M |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
📊
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 540 फाइलर्स · $9.0B कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 104 (0 पिछली तिमाही की तुलना में) | 49 (-6 पिछली तिमाही की तुलना में) | 222 (+43 पिछली तिमाही की तुलना में) | 112 (-32 पिछली तिमाही की तुलना में) | +5.3M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| VANGUARD PORTFOLIO MANAGEMENT LLC | $571778157 | 6711799 | 6.37% | शेयर |
| STATE STREET CORP | $553243709 | 6494233 | 6.16% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $521151103 | 6117515 | 5.80% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $509521049 | 5980996 | 5.67% | शेयर |
| Avoro Capital Advisors LLC | $425949915 | 4999999 | 4.74% | शेयर |
| FMR LLC | $375035430 | 4402341 | 4.18% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $259207450 | 3042018 | 2.89% | शेयर |
| BANK OF AMERICA CORP /DE/ | $251706463 | 2954648 | 2.80% | शेयर |
| RTW INVESTMENTS, LP | $243814036 | 2862003 | 2.72% | शेयर |
| Polar Capital Holdings Plc | $191988358 | 2253649 | 2.14% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $161060214 | 1890600 | 1.79% | कॉल ऑप्शन |
| Capital Research Global Investors | $143683584 | 1686625 | 1.60% | शेयर |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $136597224 | 1603442 | 1.52% | शेयर |
| Integral Health Asset Management, LLC | $136304000 | 1600000 | 1.52% | शेयर |
| Point72 Asset Management, L.P. | $135257185 | 1587712 | 1.51% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $133386924 | 1565758 | 1.49% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $131998327 | 1549458 | 1.47% | शेयर |
| PRINCIPAL FINANCIAL GROUP INC | $111435932 | 1308087 | 1.24% | शेयर |
| Capital International Investors | $111245191 | 1305848 | 1.24% | शेयर |
| ARMISTICE CAPITAL, LLC | $106487500 | 1250000 | 1.19% | कॉल ऑप्शन |
| ARMISTICE CAPITAL, LLC | $102342325 | 1201342 | 1.14% | शेयर |
| Pictet Asset Management Holding SA | $99038455 | 1160463 | 1.10% | शेयर |
| Frazier Life Sciences Management, L.P. | $98810092 | 1159879 | 1.10% | शेयर |
| Holocene Advisors, LP | $97506685 | 1144579 | 1.09% | शेयर |
| Woodline Partners LP | $93769315 | 1100708 | 1.04% | शेयर |
| NORGES BANK | $86512319 | 1015522 | 0.96% | शेयर |
| Royalty Pharma Sub-Manager, LLC | $83519594 | 980392 | 0.93% | शेयर |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $81937000 | 961815 | 0.91% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $77218175 | 906423 | 0.86% | शेयर |
| CITADEL ADVISORS LLC | $77062874 | 904600 | 0.86% | कॉल ऑप्शन |
| Melqart Asset Management (UK) Ltd | $65385455 | 767525 | 0.73% | शेयर |
| Siren, L.L.C. | $64655121 | 758952 | 0.72% | शेयर |
| Fisher Asset Management, LLC | $63355547 | 743697 | 0.71% | शेयर |
| Foresite Capital Management IV, LLC | $60884867 | 714695 | 0.68% | शेयर |
| Balyasny Asset Management L.P. | $60599821 | 711349 | 0.67% | शेयर |
| Deep Track Capital, LP | $59633000 | 700000 | 0.66% | शेयर |
| JANE STREET GROUP, LLC | $59633000 | 700000 | 0.66% | कॉल ऑप्शन |
| BNP PARIBAS FINANCIAL MARKETS | $58702470 | 689077 | 0.65% | शेयर |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | $56251809 | 660310 | 0.63% | शेयर |
| CITADEL ADVISORS LLC | $54601338 | 640936 | 0.61% | शेयर |
| GOLDMAN SACHS GROUP INC | $54053311 | 634503 | 0.60% | शेयर |
| Qube Research & Technologies Ltd | $48774257 | 572535 | 0.54% | शेयर |
| EVENTIDE ASSET MANAGEMENT, LLC | $48081832 | 564398 | 0.54% | शेयर |
| Affinity Asset Advisors, LLC | $46854500 | 550000 | 0.52% | शेयर |
| First Turn Management, LLC | $44930228 | 527412 | 0.50% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $44162525 | 518398 | 0.49% | शेयर |
| Caption Management, LLC | $43651356 | 512400 | 0.49% | कॉल ऑप्शन |
| D. E. Shaw & Co., Inc. | $40874247 | 479801 | 0.46% | शेयर |
| Checkpoint Capital L.P. | $40465250 | 475000 | 0.45% | शेयर |
| Hood River Capital Management LLC | $39977367 | 469273 | 0.45% | शेयर |
| RP Management, LLC | $39401954 | 980392 | 0.44% | शेयर |
| EMERALD ADVISERS, LLC | $39013272 | 457956 | 0.43% | शेयर |
| ADAR1 Capital Management, LLC | $39009097 | 457907 | 0.43% | शेयर |
| AMERIPRISE FINANCIAL INC | $38010006 | 446179 | 0.42% | शेयर |
| Candriam S.C.A. | $37708477 | 443066 | 0.42% | शेयर |
| MARSHALL WACE, LLP | $36259335 | 425629 | 0.40% | शेयर |
| RHUMBLINE ADVISERS | $35933015 | 421799 | 0.40% | शेयर |
| CITADEL ADVISORS LLC | $35882028 | 421200 | 0.40% | पुट ऑप्शन |
| ALLIANCEBERNSTEIN L.P. | $35327299 | 535993 | 0.39% | शेयर |
| GILDER GAGNON HOWE & CO LLC | $34096829 | 400245 | 0.38% | शेयर |
| TD Asset Management Inc | $32809225 | 385130 | 0.37% | शेयर |
| BlackRock, Inc. | $29124928 | 341882 | 0.32% | शेयर |
| GSK plc | $29001573 | 340434 | 0.32% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $27040243 | 317411 | 0.30% | शेयर |
| CITIGROUP INC | $26852314 | 315205 | 0.30% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $24671024 | 289600 | 0.27% | पुट ऑप्शन |
| Trails Edge Capital Partners, LP | $24542302 | 288089 | 0.27% | शेयर |
| EMERALD MUTUAL FUND ADVISERS TRUST | $23833521 | 279769 | 0.27% | शेयर |
| Polaris Capital Management, LLC | $22737211 | 266900 | 0.25% | शेयर |
| SEGALL BRYANT & HAMILL, LLC | $21899197 | 257063 | 0.24% | शेयर |
| Alyeska Investment Group, L.P. | $21297500 | 250000 | 0.24% | शेयर |
| ExodusPoint Capital Management, LP | $21234374 | 249259 | 0.24% | शेयर |
| Capital World Investors | $21196550 | 248815 | 0.24% | शेयर |
| Walleye Capital LLC | $20422428 | 239728 | 0.23% | शेयर |
| E. Ohman J:or Asset Management AB | $19823223 | 300762 | 0.22% | शेयर |
| Sarissa Capital Management LP | $19476393 | 228623 | 0.22% | शेयर |
| Swiss National Bank | $18946256 | 222400 | 0.21% | शेयर |
| SPHERA FUNDS MANAGEMENT LTD. | $18740693 | 219987 | 0.21% | शेयर |
| BAKER BROS. ADVISORS LP | $17997836 | 211267 | 0.20% | शेयर |
| California Public Employees Retirement System | $17979520 | 211052 | 0.20% | शेयर |
| Nicholas Investment Partners, LP | $17810758 | 209071 | 0.20% | शेयर |
| PINNACLE ASSOCIATES LTD | $17245864 | 202440 | 0.19% | शेयर |
| Mirador Capital Partners LP | $17239900 | 202370 | 0.19% | शेयर |
| Tri Locum Partners LP | $16526860 | 194000 | 0.18% | शेयर |
| PFM Health Sciences, LP | $16329730 | 191686 | 0.18% | शेयर |
| Rock Springs Capital Management LP | $16014016 | 187980 | 0.18% | शेयर |
| PRUDENTIAL FINANCIAL INC | $15933512 | 187035 | 0.18% | शेयर |
| DAFNA Capital Management LLC | $14652510 | 171998 | 0.16% | शेयर |
| Ghisallo Capital Management LLC | $14482300 | 170000 | 0.16% | शेयर |
| Impax Asset Management Group plc | $14056350 | 165000 | 0.16% | शेयर |
| Lombard Odier Asset Management (Europe) Ltd | $13494096 | 158400 | 0.15% | कॉल ऑप्शन |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $13383349 | 157100 | 0.15% | शेयर |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $13330276 | 156477 | 0.15% | शेयर |
| JANE STREET GROUP, LLC | $12735905 | 149500 | 0.14% | पुट ऑप्शन |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $12145719 | 139190 | 0.14% | शेयर |
| Retirement Systems of Alabama | $11962891 | 140426 | 0.13% | शेयर |
| MetLife Investment Management, LLC | $11930519 | 140046 | 0.13% | शेयर |
| Polymer Capital Management (HK) LTD | $11777943 | 138255 | 0.13% | शेयर |
| Cinctive Capital Management LP | $11742419 | 137838 | 0.13% | शेयर |
| TUDOR INVESTMENT CORP ET AL | $11279156 | 132400 | 0.13% | कॉल ऑप्शन |
कंपनी के अंदरूनी सूत्र 52 इनसाइडर्स · 18 अधिकारी · 22 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Sung Lee | EVP, Chief Financial Officer | 1 जुलाई 2026 M | 63221 | 0 | 5 | $-5695855 |
| Ching Jaw | SVP Finance & CFO | 6 मार्च 2023 A | 87346 | 0 | 0 | $0 |
| Sharon Surrey Barbari | EVP, Finance & CFO | 28 फ़रवरी 2017 F | 40323 | 0 | 0 | $0 |
| Fady Ibraham Malik | EVP Research & Development | 18 अगस्त 2026 M | 153902 | 0 | 21 | $-4352750 |
| Andrew Callos | EVP, Chief Commercial Officer | 30 जुलाई 2026 M | 58555 | 0 | 24 | $-15318893 |
| Jeffrey Hessekiel | Chief Legal & Admin Officer | 15 मार्च 2026 A | 107943 | 0 | 0 | $0 |
| Robert Wong | VP, Chief Accounting Officer | 3 दिसमबर 2024 A | 18655 | 0 | 0 | $0 |
| Brett A Pletcher | EVP, Chief Legal Officer | 30 अगस्त 2024 A | 33140 | 0 | 0 | $0 |
| Mark A Schlossberg | SVP - Legal & General Counsel | 15 मार्च 2022 M | 103408 | 0 | 0 | $0 |
| David Cragg | Chief HR & Admin Officer | 7 मार्च 2022 F | 153233 | 0 | 0 | $0 |
| Caryn Gordon Mcdowell | GC & Chief Compliance Officer | 27 फ़रवरी 2018 A | 32548 | 0 | 0 | $0 |
| Peter S Roddy | SVP Finance & CAO | 27 फ़रवरी 2018 A | 21520 | 0 | 0 | $0 |
| Bradley Paul Morgan | SVP Drug Discovery & Early Dev | 31 अगस्त 2017 M | 46441 | 0 | 0 | $0 |
| Bonnie Charpentier | SVP Regulatory & Compliance | 28 फ़रवरी 2017 A | 29004 | 0 | 0 | $0 |
| Andrew A Wolff | SVP & CMO | 28 फ़रवरी 2017 A | 47255 | 0 | 0 | $0 |
| David J Morgans JR | EVP-Preclinical R&D | 28 फ़रवरी 2011 A | 42000 | 0 | 0 | $0 |
| Michael Rabson | SVP Business Dev/Legal & GC | 18 दिसमबर 2009 M | 20043 | 0 | 0 | $0 |
| Jay K Trautman | VP, Discovery Research | 29 फ़रवरी 2008 A | 47896 | 0 | 0 | $0 |
| Robert Arthur Harrington | निदेशक | 15 जुलाई 2026 A | 21932 | 0 | 2 | $-248260 |
| James M Daly | निदेशक | 15 जुलाई 2026 A | 3390 | 0 | 0 | $0 |
| Edward M. Kaye MD | निदेशक | 15 जुलाई 2026 A | 10434 | 0 | 6 | $-3544372 |
| Nancy Wysenski | निदेशक | 15 जुलाई 2026 A | 33992 | 0 | 0 | $0 |
| Wendell Wierenga | निदेशक | 15 जुलाई 2026 A | 35563 | 0 | 3 | $-1881925 |
| John T Henderson | निदेशक | 15 जुलाई 2026 A | 78360 | 0 | 2 | $-2078525 |
| Lynne B Parshall | निदेशक | 1 जून 2026 S | 15784 | 0 | 3 | $-1000100 |
| Muna Bhanji | निदेशक | 27 मई 2026 A | 26361 | 0 | 0 | $0 |
| Robert E Landry | निदेशक | 27 मई 2026 A | 10184 | 0 | 0 | $0 |
| Wendall Wierenga | निदेशक | 15 जुलाई 2025 A | 32345 | 0 | 0 | $0 |
| COSTA SANTO J | निदेशक | 15 मई 2024 A | 20600 | 0 | 0 | $0 |
| Sandford D Smith | निदेशक | 2 जनवरी 2024 A | 18801 | 0 | 0 | $0 |
| Robert Califf | निदेशक | 3 जनवरी 2022 A | 6003 | 0 | 0 | $0 |
| GAGE L PATRICK | निदेशक | 8 नवमबर 2021 M | 28932 | 0 | 0 | $0 |
| Denise Gilbert | निदेशक | 20 मई 2015 J | — | 0 | 0 | $0 |
| Stephen M Dow | निदेशक | 2 जनवरी 2013 A | 1421052 | 0 | 0 | $0 |
| James A Spudich | निदेशक | 18 मई 2011 A | 180600 | 0 | 0 | $0 |
| Grant A Heidrich III | निदेशक | 3 जनवरी 2011 A | 93755 | 0 | 0 | $0 |
| Michael Schmertzler | निदेशक | 3 जून 2010 S | 4340923 | 0 | 0 | $0 |
| Mark Mcdade | निदेशक | 21 मई 2009 A | — | 0 | 0 | $0 |
| Charles J Homcy | निदेशक | 22 मई 2008 A | — | 0 | 0 | $0 |
| William J Rutter | निदेशक | 29 अप्रैल 2004 C | 172413 | 0 | 0 | $0 |
| SEVIN ROSEN FUND VI LP | 10% मालिक | 29 अप्रैल 2004 C | 1615716 | 0 | 0 | $0 |
| SRB ASSOCIATES VIII LP | 10% मालिक | 29 अप्रैल 2004 C | 771052 | 0 | 0 | $0 |
| SRB ASSOCIATES VII LP | 10% मालिक | 29 अप्रैल 2004 C | 650000 | 0 | 0 | $0 |
| SEVIN ROSEN FUND VIII LP | 10% मालिक | 29 अप्रैल 2004 C | 755631 | 0 | 0 | $0 |
| Robert I Blum | — | 10 अगस्त 2026 M | 377820 | 0 | 19 | $-9702097 |
| Elisabeth Schnieders | — | 28 फ़रवरी 2017 A | 43919 | 0 | 0 | $0 |
| James H Sabry | — | 3 जून 2010 M | 0 | 0 | 0 | $0 |
| SEVIN ROSEN VII AFFILIATES FUND LP | — | 29 अप्रैल 2004 C | 24050 | 0 | 0 | $0 |
| SEVIN ROSEN FUND VII LP | — | 29 अप्रैल 2004 C | 625950 | 0 | 0 | $0 |
| SRB ASSOCIATES VI LP | — | 29 अप्रैल 2004 C | 1742951 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 84 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 3.16% | 43268 NS | 31 मई 2026 | N-PORT |
| HRTS · Tema ETF Trust | 2.52% | 17069 NS | 31 मई 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1.55% | 8262 NS | 31 मई 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 1.40% | 3663 NS | 31 मई 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 1.24% | 189801 NS | 30 अप्रैल 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0.98% | 48338 NS | 30 अप्रैल 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.94% | 76297 NS | 30 अप्रैल 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0.75% | 4355 NS | 30 अप्रैल 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.51% | 41612 NS | 30 अप्रैल 2026 | N-PORT |
| BIB · ProShares Trust | 0.47% | 4553 NS | 31 मई 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0.47% | 94565 NS | 30 अप्रैल 2026 | N-PORT |
| MIDE · DBX ETF Trust | 0.41% | 178 NS | 29 मई 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.34% | 16959 NS | 30 अप्रैल 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.26% | 55086 NS | 30 अप्रैल 2026 | N-PORT |
| ITWO · ProShares Trust | 0.25% | 6062 NS | 31 मई 2026 | N-PORT |
| RSSL · Global X Funds | 0.23% | 51834 NS | 30 अप्रैल 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0.23% | 14028 NS | 30 अप्रैल 2026 | N-PORT |
| MVV · ProShares Trust | 0.22% | 4565 NS | 31 मई 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.21% | 635330 NS | 31 मई 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.20% | 19862 NS | 30 अप्रैल 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0.19% | 356940 NS | 31 मई 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0.19% | 37821 NS | 30 अप्रैल 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.15% | 2025 NS | 30 अप्रैल 2026 | N-PORT |
| UMDD · ProShares Trust | 0.15% | 638 NS | 31 मई 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.15% | 11444 NS | 30 अप्रैल 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.15% | 47609 NS | 30 अप्रैल 2026 | N-PORT |
| UWM · ProShares Trust | 0.15% | 4765 NS | 31 मई 2026 | N-PORT |
| SMDX · Tidal Trust III | 0.15% | 2868 NS | 30 अप्रैल 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.12% | 53720 NS | 30 अप्रैल 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.12% | 154 NS | 31 मई 2026 | N-PORT |
| NBCR · Neuberger Berman ETF Trust | 0.10% | 12090 NS | 31 मई 2026 | N-PORT |
| URTY · ProShares Trust | 0.10% | 4793 NS | 31 मई 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0.06% | 2263 NS | 31 मई 2026 | N-PORT |
| FFLG · FIDELITY COVINGTON TRUST | 0.06% | 5490 NS | 30 अप्रैल 2026 | N-PORT |
| ESLV · Strategy Shares | 0.05% | 100 NS | 30 अप्रैल 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.05% | 4582 NS | 31 मई 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.05% | 5851 NS | 31 मई 2026 | N-PORT |
| HDG · ProShares Trust | 0.04% | 121 NS | 31 मई 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.02% | 30621 NS | 31 मई 2026 | N-PORT |
| TILT · FlexShares Trust | 0.02% | 5462 NS | 30 अप्रैल 2026 | N-PORT |
| SCHK · SCHWAB STRATEGIC TRUST | 0.01% | 10669 NS | 31 मई 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.01% | 78165 NS | 31 मई 2026 | N-PORT |
| GUSA · Goldman Sachs ETF Trust II | 0.01% | 3973 NS | 31 मई 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.01% | 570 NS | 31 मई 2026 | N-PORT |
| AVLC · AMERICAN CENTURY ETF TRUST | 0.01% | 1547 NS | 31 मई 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.01% | 173 NS | 31 मई 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | -0.10% | -35935 NS | 30 अप्रैल 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 जुलाई 2026 | दैनिक |
| VB · VANGUARD INDEX FUNDS | — | — | 15 जुलाई 2026 | दैनिक |
| VBK · VANGUARD INDEX FUNDS | — | — | 15 जुलाई 2026 | दैनिक |